Also, due to the recent development of photopharmacology and optochemical genetics of TRPC3 that could be the foundation for novel therapeutics [25], these discoveries highlight pharmacological targeting of TRPC3 as an attractive new strategy for the treatment of sepsis and inflammatory diseases. Here, TRPC3 is linked to Sepsis.